These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 28545023)
1. Long non-coding RNA HOXA-AS2 promotes proliferation and invasion of breast cancer by acting as a miR-520c-3p sponge. Fang Y; Wang J; Wu F; Song Y; Zhao S; Zhang Q Oncotarget; 2017 Jul; 8(28):46090-46103. PubMed ID: 28545023 [TBL] [Abstract][Full Text] [Related]
2. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma. Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263 [TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway. Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells. Wang Y; Zhang R; Cheng G; Xu R; Han X Cell Cycle; 2018; 17(13):1637-1648. PubMed ID: 30081707 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis. Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression. Li Z BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis. Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p. Liu Y; Lin X; Zhou S; Zhang P; Shao G; Yang Z Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064819 [No Abstract] [Full Text] [Related]
9. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis. Xiao S; Song B Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740 [TBL] [Abstract][Full Text] [Related]
10. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3. Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression. Xie M; Sun M; Zhu YN; Xia R; Liu YW; Ding J; Ma HW; He XZ; Zhang ZH; Liu ZJ; Liu XH; De W Oncotarget; 2015 Oct; 6(32):33587-601. PubMed ID: 26384350 [TBL] [Abstract][Full Text] [Related]
12. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma. Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366 [TBL] [Abstract][Full Text] [Related]
13. LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis. Jiang L; Wu Z; Meng X; Chu X; Huang H; Xu C Hum Gene Ther; 2019 May; 30(5):618-631. PubMed ID: 30375256 [TBL] [Abstract][Full Text] [Related]
14. Knocking Down lncRNA HOXA-AS2 Mitigates the Progression of Epilepsy via Regulation of the miR-372-3p/STAT3 Axis. Song L; Li J; Sun Z Turk Neurosurg; 2023; 33(5):781-789. PubMed ID: 36482855 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma. Zhang P; Cao P; Zhu X; Pan M; Zhong K; He R; Li Y; Jiao X; Gao Y Oncotarget; 2017 May; 8(20):33137-33143. PubMed ID: 28388535 [TBL] [Abstract][Full Text] [Related]
16. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Wang J; Su Z; Lu S; Fu W; Liu Z; Jiang X; Tai S Clin Chim Acta; 2018 Oct; 485():229-233. PubMed ID: 29981289 [TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis. Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA HOXA-AS2 accelerates cervical cancer by the miR-509-3p/BTN3A1 axis. Chen R; He P J Pharm Pharmacol; 2021 Sep; 73(10):1387-1396. PubMed ID: 34240204 [TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori infection induces gastric cancer cell malignancy by targeting HOXA-AS2/miR-509-3p/MMD2 axis. Cheng S; Jia Y; Wu J; Li J; Cao Y Genes Genomics; 2024 Jun; 46(6):647-657. PubMed ID: 38573409 [TBL] [Abstract][Full Text] [Related]
20. HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3. Sun J; Wang L BMC Cancer; 2022 Apr; 22(1):366. PubMed ID: 35387643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]